Back
Applied Therapeutics, Inc. Vs. Nektar Therapeutics Industry Stock Comparison
Sell
11
APLT
Applied Therapeutics, Inc.
Last Price:
$0.11
Seasonality Move:
28.77%
Sell
39
NKTR
Nektar Therapeutics
Last Price:
$53.73
Seasonality Move:
11.58%
Sell
11
Applied Therapeutics, Inc. (APLT)
is a Sell
Is Applied Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Applied Therapeutics, Inc. [APLT] share price is $0.12. The Score for APLT is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
APLT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLT Stock Price Chart
What is Applied Therapeutics, Inc.'s stock price today?
-
The Applied Therapeutics, Inc. share price today is $0.12Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLT is experiencing slight selling pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $54.70Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.
APLT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 25.69 | Sell |
| Chaikin Money Flow: | -9389238 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.1 - 0.58) | Sell |
| Bollinger Bands (100): | (0.27 - 0.99) | Sell |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.71 | Sell |
| Relative Strength Index (14 RSI): | 45.77 | Sell |
| Chaikin Money Flow: | 141668 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.71 - 61.07) | Sell |
| Bollinger Bands (100): | (32.74 - 62.56) | Buy |
APLT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.21 | Sell |
| 20-day SMA: | 0.24 | Sell |
| 50-day SMA: | 0.75 | Sell |
| 200-day SMA: | 0.52 | Sell |
| 8-day EMA: | 0.21 | Sell |
| 20-day EMA: | 0.32 | Sell |
| 50-day EMA: | 0.53 | Sell |
| 200-day EMA: | 1.02 | Sell |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.42 | Sell |
| 20-day SMA: | 58.12 | Sell |
| 50-day SMA: | 58.41 | Sell |
| 200-day SMA: | 30.65 | Buy |
| 8-day EMA: | 56.16 | Sell |
| 20-day EMA: | 57.43 | Sell |
| 50-day EMA: | 55.78 | Sell |
| 200-day EMA: | 37.86 | Buy |
Applied Therapeutics, Inc. Earnings Growth & APLT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.81 per share, and an increase next year of $0.14 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.
Applied Therapeutics, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||